Clinical Trial Update: Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)

View source ↗

Summary

This clinical trial update reports results from a completed study evaluating pegfilgrastim given on the same day as or the day after carboplatin and docetaxel i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Amgen | Conditions: Lung Cancer, Non-Small Cell Lung Cancer | Status: COMPLETED